Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy
Incidence of Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy: a Multicenter Randomized Controlled Trial
Samsung Medical Center
202 participants
Apr 14, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to investigate whether the use of bronchial blocker could reduce the incidence of postoperative vocal cord palsy than the use of double-lumen endobronchial tube in robot-assisted esophagectomy.
Eligibility
Inclusion Criteria5
- Adults aged 19 or older
- American Society of Anesthesiologists physical status I - III
- Elective robot-assisted esophagectomy
- Any clinical stage of esophageal cancer
- Patients who need recurrent laryngeal nerve lymph nodes resection
Exclusion Criteria6
- Patients who diagnosed vocal cord palsy or damage before surgery
- Patients who need specific airway device due to airway problem
- History of thoracic surgery
- Emergency surgery
- Combined surgery with other department
- Pregnant or nursing women
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Lung isolation for robot-assisted esophagectomy will be performed using bronchial blocker in this group.
Lung isolation for robot-assisted esophagectomy will be performed using double-lumen endobronchial tube in this group.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06897501